Be-Music Source, called BMS for short, is a file format devised by Urao Yane in 1998 for a simulator of the game Beatmania by KONAMI. This describes what and when notes are arranged and its music ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

报道援引消息人士的话称，现代汽车考虑直接采用中国混动方案，一个出发点是为了降本。“如果在 TMED-II 的基础上开发，各种验证都要从头做，开发周期长，还需要投入巨额的开发费用。”直接采用中国本土方案，对现代汽车来说，是成本和效率的更优解。据了解，目前双方还在初步接触阶段。

Bristol Myers Squibb and insitro first partnered in 2020 to develop induced pluripotent stem cell models of amyotrophic lateral sclerosis and frontotemporal dementia. Last December, BMS exercised its ...

Abstract: This paper investigates State of Charge (SoC) estimation and Constant Current-Constant Voltage (CC-CV) charging techniques for Lithium-Ion (Li-Ion) batteries for Electric Vehicles (EVs) ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus erythematosus and plaque psoriasis, and $300 million in funds from Bain Capital.

Bristol Myers Squibb (BMS) has agreed to co-develop and co-commercialize BioNTech’s cancer-fighting bispecific antibody candidate BNT327 across numerous solid tumor types through a collaboration that ...

BMS and BioNTech are now contestants in a fast-moving clinical arena that looks to go beyond traditional single-mechanism checkpoint inhibitors. HJBC via Shutterstock. Bristol Myers Squibb (BMS) is ...

Why I am doing this work ?? I noticed that many lithium battery recyclers throwing the BMS boards in the garbage, although they are important and could be recycled also. I have noticed that you will ...

Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and Abecma, Bristol Myers Squibb is rethinking its operations at the site. BMS ...